CTOs on the Move

Talaris Therapeutics

www.talaristx.com

 
Talaris Therapeutics is a late-clinical stage biotechnology company based in Boston, MA and Louisville, KY. Talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. The company was founded on technology discovered and developed by Dr. Suzanne Ildstad and operates its own cell processing facility in Louisville. Talaris is backed by leading life sciences investors Blackstone Life Sciences, Longitude Capital and Qiming Venture Partners USA.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.talaristx.com
  • 201 East Jefferson Street Suite 110B
    Louisville, KY USA 40202
  • Phone: 502.569.1059

Executives

Name Title Contact Details
Michael Zdanowski
Chief Technology Officer Profile
Eric Gornstein
Head of New Product Planning Profile
Carlos Yuraszeck
Senior Vice President of Technical Operations Profile

Funding

Talaris Therapeutics raised 4/18/2019 on 05/03/2019

Similar Companies

Carterra

Carterra, formerly Wasatch Microfluidics, develops high throughput surface plasmon resonance array-based platforms for biomolecular interaction analysis.

GeneGo bioinformatics software

GeneGo bioinformatics software, Inc. is a Saint Joseph, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MouldWorks

MouldWorks is a Beulah, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiome Pharma

Cardiome Pharma Corp. is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alpine Immune Sciences

Alpine Immune Sciences is a clinical stage biopharmaceutical company dedicated to discovering and developing innovative, protein-based immunotherapies targeting the immune synapse to treat autoimmune and inflammatory diseases. We have two products in the clinic for inflammatory diseases, collaborations with world-class partners, and a robust development pipeline. Traded on NASDAQ under ticker ALPN.